PT  - JOURNAL ARTICLE
AU  - D R Sutton
TI  - Gastric ulcer healing with tripotassium dicitrato bismuthate and subsequent relapse.
AID  - 10.1136/gut.23.7.621
DP  - 1982 Jul 01
TA  - Gut
PG  - 621--624
VI  - 23
IP  - 7
4099  - http://gut.bmj.com/content/23/7/621.short
4100  - http://gut.bmj.com/content/23/7/621.full
SO  - Gut1982 Jul 01; 23
AB  - Fifty patients with endoscopically proven gastric ulcers completed a one month double-blind randomised trial of tripotassium dicitrato bismuthate (TBD) (DeNol) compared with an identical placebo. Ulcer healing occurred in 18 (72%) of the 25 patients given TDB and in nine (36%) of the patients given placebo. The TDB group experienced significantly less pain than the placebo group. During a follow-up of 29 patients with healed ulcers for up to 44 months, relapse occurred in 13 (45%). It was highest in the first three months (27%) and had risen to 41% at two years.